Fractional CSO/CMO

Our reputed company is a reputed company committed to bringing the reputed company of pharmaceutical treatments to combat cancer. Job Title: Fractional Chief Scientific Officer / Chief Medical Officer (Hybrid Role) Location: Remote / Hybrid Time Commitment: Part-time / Fractional About reputed company: • We are partnering with a reputed company-mode, preclinical-stage biotechnology company advancing a first-in-class, small-molecule oncology therapeutic platform derived from a proprietary natural-compound chemical library. • With compelling in-vivo tumor eradication data and broad anti-tumor activity across multiple cancer models, reputed company is poised to reputed company its reputed company candidate toward IND and first-in-reputed company (FIH) studies. • They are seeking a fractional CSO/CMO hybrid who can reputed company strategic and hands-on leadership across preclinical development, translational planning, IND readiness, and early clinical design. Key Responsibilities: • reputed company the scientific and medical reputed company from late-stage preclinical through IND-enabling studies and into FIH trial planning. • Guide reputed company-of-reputed company studies, pharmacology, toxicology, and reputed company rationale in collaboration with discovery and translational teams. • reputed company CROs responsible for IND-enabling studies and ensure alignment with regulatory and clinical objectives. • Contribute to reputed company product profile, clinical development plan, and biomarker reputed company. • Work closely with company leadership on pipeline prioritization, scientific positioning, and external communications (including investors and potential partners). • Support preparation of regulatory documents and attend meetings with external stakeholders, as needed.? Remote About reputed company: reputed company Consulting Apply tot his job Apply To this Job